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ABSTRACT 
Objective: The aim of the present work was to formulate silk fibroin (SF) nanospheres (NS’s) for drug delivery application. The current study was 
designed to advance the water solubility and bio-availability of telmisartan by nanoprecipitation method.  
Methods: SF NS’s loaded with TS were prepared by nanoprecipitation method. The drug was dissolved in aqueous solution of SF by using acetone 
as a non-solvent. The prepared NS’s were then characterized by FTIR, X-ray diffraction and zeta potential, and were evaluated for its, surface 
morphology, %drug content, encapsulation efficiency and in vitro drug release. 
Results: The evaluation results of SF NS’s loaded of TS showed 74.22±0.17 % entrapment efficiency, 35.21±0.02 % of drug loading, and-4.9 mV to-
13.6 mV of zeta potential due to the proper bounding of TS with the β-sheets of SF, the particle size reported was within the size range of 160-186 
nm having smooth surface and were spherical in shape. The SFNS’s pattern switched from random coil to β-sheet formation on treating with 
acetone. FTIR and DSC studies marked no such inter-molecular interactions between SF and drug molecules. The % cumulative in vitro drug release 
from SF NS’s exhibited quick burst release. The in vitro cumulative drug release of SF NS’s of TS it was found that about 74% of the drug was 
released within 8 h and about 96% of drug released at 24 hr. The rate of drug release increased with the increase in SF ratio.  
Conclusion: It is believed that these SF NS’s will find potential applications in drug delivery release as drug carriers, especially poor water-soluble 
drugs. All these results proposed that SF NS’s are eventuality handy in various drug delivery systems. 
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Silk fibroin (SF) obtained from Bombyx mori silk cocoons are one of 
the proteins which have been extensively explored in the biomedical 
and pharmaceutical domain [1, 2]. Some researchers have reported 
various processes to develop the SF nanospheres by self-build of SF 
macromolecules. Researchers have found that Regenerated-SF and 
poly-(vinyl alcohol) PVA were macroscopically or microscopically 
separated into various stages in SF/poly-(vinyl alcohol) blend films. 
SF microspheres or nanospheres have been attained by establishing 
the blend film into H2O to diffuse the poly (vinyl alcohol) factor [3-
5]. Zhang et al., 2007 formed regenerated-SF nanospheres by the 
simple addition of regenerated-SF solution into the H2O-miscible 
polar organic solvents, such as C2H5OH, CH3OH, n-C3H7OH, C3H8O, 
C4H8O, and C3H6O [6]. Regenerated Silk Fibroin (RSF) devices, for e. 
g., fibers, nanospheres, films and particles have been reported for 
various applications [7]. Due to their degradation properties bio-
degradable polymeric nanospheres have been often proposed to be 
used in controlled release drug delivery systems [8, 9]. Telmisartan 
(TS) is an anti-hypertensive drug. It is an angiotensin-II receptor 
antagonist. It acts by the binding to the angiotensin-II type-I 
receptors, ensuing in the inhibition of angiotensin-II on vascular 
smooth muscles. As angiotensin-II is a vasoconstrictor [10], 
inhibition of its effect on vascular smooth muscles [11] results in 
decreases in systemic vascular resistance [12]. TS come under the 
class-II of BCS Class. Essentially, as a BCS class-II drug, TS is very 
poorly soluble in H2O, which results in the reduced dissolution and 
accordingly lower bioavailability when dispensed orally [13-15, 35-
36]. By using the hydrophobic carriers to overcome the lower 
bioavailability, SF as a carrier can be used to increase the 
bioavailability of TS. Furthermore, C3H6
SF obtained from Bombyx mori silk, a type of natural protein 
polymer with very well bio-compatibility and biodegradability [1], 
and has newly been broadly explored as a bio-material, such as a 
matrix for cell-based culture substrates [16] and drug delivery 
systems [17]. These objectives, SF based materials such as films [18] 
microparticles [5] and nanoparticles [6] nanospheres [19], had been 
prepared and described. The minimum inflammatory reactions in 
vitro and in vivo of SF matrices have also been described by [20]. 
O functioned both as the 
solvent of TS and the additive for NS formulation, which assembled 
the procedure easy and further productive. 
  
 
Schema 1: Depiction of telmisartan encapsulating with silk fibroin nanospheres 
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In the present work, we developed a novel and simplistic procedure 
to formulate SF nanospheres for drug delivery application. 
Telmisartan-silk fibroin nanospheres (TSSF-NS) were produced by 
amassing of silk fibroin protein in aq. sol. at RT devoid of casting any 
harmful organic solvents, surfactants or other toxin ingredients. The 
current study was designed to advance the water solubility and bio-
availability of telmisartan by nanoprecipitation method. The 
developed SFNS as a carrier for TS, the hydrophobic core of SFNS 
yields the right domain to encapsulate TS by hydrophobic 
interactions, with that nanospheres showed TS got attached with the 
β-sheets form of SF as shown in (schema 1). 
In addition, we also explored the influence of different ratios of silk 
fibroin with regards to drug release. The investigation further 
figured the encapsulated telmisartan nanospheres (TSSF-NSs), for 
encapsulation, drug loading, particle size, surface properties, their 
morphology of SFNS
MATERIALS AND METHODS 
’s and it’s in vitro drug release and release 
kinetics to explore its use as a potential drug delivery carrier.  
Materials  
Bombyx mori Silk Cocoons were provided by Central Sericultural 
Research and Training Institute, Mysuru, India. Telmisartan was 
gifted by Vowcare Pharma, JandK. A. R. grade Sodium Carbonate 
(Na2CO3) and Acetone (C3H6O). were obtained from Loba Chemie 
Pvt. Ltd., India. Lithium Bromide was obtained from Axiom 
Chemicals, Gujarat, India. dd-H2
Methods 
O was obtained from Nice Chemicals, 
Kerala, India. All reagents were of A. R. grade. 
Preparation of silk fibroin solution  
As described in earlier methods [21], Bombyx mori silk cocoons were 
cropped into little slices and heated for about 45 min in aq. sol. of 
0.02M Na2CO3, and then washed meticulously with dd-H2O. 
Afterward desiccating at RT, the de-gummed silk was mixed in 9.3 M 
of aq., Lithium Bromide solution. After dialysing against dd-H2O for 
96 h at RT by using 3.5 kDa cut off dialysis cassette, the silk fibroin 
(SF) aq., the solution was centrifuged at 9000 rpm per min for 15 
min to detach traces of fibres. The conc. of SF sol. was measured by 
weighting technique. Lastly, the SF sol. was diluted with a certain 
conc of dd-H2
Preparation of drug-loaded silk fibroin nanospheres 
O water and stored at 2-4 °C for further use. 
Telmisartan (TS) loaded silk fibroin (SF) nanospheres (NS’s) were 
obtained by a nanoprecipitation technique in acetone (Zhang et al., 
2007) [6]. The nature of the method was elucidated as follows. An 
appropriate amount of drug was dissolved in 2.5 ml of SF solution with 
drug: SF ratios of 1:1, 1:2 and 1:3 and 1:4 (w/w). The solution was 
poured into 10 ml of acetone with stirring. The suspensions of TS-
loaded nanospheres were maintained for 2h. Then the TS-loaded 
nanospheres were recovered by centrifugation at 9,500 rpm for 15 
min to separate these nanospheres from acetone medium before the 
freeze-drying. The SFNS’s without drug loading was also prepared as a 
control. 
Determination of % yield, entrapment efficiency, and drug 
loading  
Determination of % yield of nanospheres of telmisartan (TS) was 




 X 100 
The prepared nanospheres of TS were centrifuged with 10 ml of 
methanol at 4500 rpm for 15 min. The free amount of the TS loaded 
NS’s in the filtrate was determined by UV-Vis spectroscopy at 270 
nm respectively. Measurements were observed in triplicate. The 
entrapment efficiency (EE) and drug loading (DL) were calculated by 
the following formula [18]:  
EE =
Tot. Amt. of drug– Amt. of free drug 
Tot. Amt. of drug
 X 100  
DL =
Wt. of the drug drug 
Wt. of the nanospheres
 X 100 
Determination of particle size (PS) and zeta potential (ZP) and 
stability studies of silk telmisartan loaded fibroin nanospheres 
The mean dia of TS loaded nanospheres were measured by laser 
diffraction using a NANOTRAC WAVE II instrument (Microtrac, U. S. 
A.) at a determined scattering angle of 90 ° at 25 °C. Zeta potential is 
a commonly used the parameter to characterize the surface charge 
property and stability of nanospheres. The SFNS loaded with 
Telmisartan, were diluted with dd-H2
The stability of prepared nanosphere was determined [23], by 
monitoring their mean particle size and zeta potential in de-ionized 
water using DLS particle size analyzer at a fixed angle of 90 ° at 27 
°C. After preparation, the nanospheres were incubated at 37 °C in 
the incubator, and their sizes were determined after 1, 6, 12, 24, 48, 
96, and 168 h respectively. 
O and PS and ZP were 
determined [22]. 
FTIR analysis 
Functional groups of SF and drug (TS) of the NS’s and interactions 
b/w them were studied by FT-IR spectroscopy using FTIR-
spectrophotometer (Shimadzu-8400, Japan), taking air as a 
reference. The resolution of 4 cm-1
DSC studies 
 and 32 scans were used. FT-IR 
spectrum was obtained from a KBr disk of dried NS’s [24]. 
Thermal properties of the NS’s were determined by 
thermogravimetry (TG) by using TA-Instrument (Shimadzu DSC-60, 
Japan), TGA. For TG analysis, sample (10 mg) was heated from 50 ° 
to 350 °C at a heating rate of 20 °C/min under nitrogen atmosphere. 
X-Ray diffraction studies  
XRD patterns of pure TS and TS-SFNS5 were attained using a 
powder X-ray diffract meter (Rigaku Ultima III), Rigaku Corporation, 
Japan. The samples were studied by locating a thin sheet of powder 
in the traditional cavity frames. The scanning rate was 2.5 °/min at a 
diffracting angle (2θ) of 0 to 45 °C. 
SEM analysis 
Morphologies of nanospheres were investigated by scanning 
electron microscopy (SEM) using a Hitachi NORAN System 7 (Japan). 
The nanospheres were coated with Au for improving conductivity 
before the scan. The avg. sizes of nanospheres were determined 
from various SEM images counting a least of 100 particles by using 
smile view software (version 1.02). 
In vitro drug release 
Specific amt (about 5 mg) of TS-loaded NS was placed into a dialysis 
membrane tube containing 3.0 ml of Phosphate Buffer Solution 
(PBS) having a pH of 7.4. The sampling tubes were enshrouded at 37 
°C at the shaking rate of 120 rpm [25-27]. At changed time intervals, 
the tubes were centrifuged at 9,500 rpm for 10 min before 
separating the PBS medium. After that freshly prepared 3 ml of PBS 
was added into the tube for continuing release test. UV-Vis 
spectrophotometer was used to measure the released telmisartan. 
As stated, to a different telmisartan conc. in absorbance standard 
curve, telmisartan conc. of the release, medium was observed and % 
telmisartan release was calculated. Each avg. the value was cal. from 
the three measurements. 
Release Kinetics 
Data obtained from in vitro analysis were adapted to different 
kinetic equations to establish the method of drug release from SF 
nanospheres. The kinetic equations used were zero-order equation, 
1st
C= k





Log C = LogC
 is zero order rate constant defined in units of conc./t and (t) time. 
0-k1 t/2.303 
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Where C0 is the incipient conc. of drug and k1 is 1st-order constant. 
Q=kHt1/2 
Where (kH), is Higuchi constant musing scheme parameters of the 
system. 
The rate constants were designed for the individual models. 
Additional, to locate out the process of drug release, the first 50% 
drug release was ensuite in Korsmeyer–Peppas model [30]: 
Qt = ktn
RESULT AND DISCUSSION 
  
Where k is the kinetic-constant and n is the diffusion-exponent, an 
evaluation of the 1 ° means of the drug release. 
Statistical analysis 
All reports were listed as mean±sem. Statistical analyses of reports 
were made by ANOVA or Student’s t-test. It was assessed 
considerably distinct if p<0.05. 
Evaluation of telmisartan loaded-silk fiboin nanosphere’s 
The prepared nanospheres were evaluated for physical appearance, 
% yield, entrapment efficiency (EE), drug loading (DL), particle size 
(PS) and zeta potential (ζ). The physical appearance of the silk 
fibroin nanospheres loaded with telmisartan was found to be yellow 
whitish colour powder and odourless. The silk fibroin loaded 
nanospheres of telmisartan were prepared by the aqueous solvent 
method as mentioned in (table 1); also earlier methods used by [34] 
in their studies, methanol (or ethanol) was commonly used the 
method to increase β-sheet content. In the present study, acetone 
containing pure telmisartan (TS) was directly added to the silk 
fibroin solution so as to increase the drug loading and drug release. 
Entrapment efficiency and drug loading 
The evaluation results of silk fibroin nanosphere formulations 
(TSSF-NS1 to TSSF-NS5) of telmisartan showed lowest 42.18±0.23 
% and highest 58.13±0.21 % yield respectively given in (table 2). 
 
Table 1: Composition of telmisartan loaded silk fibroin nanospheres 
S. No. Formulation code Ratios 
Telmisartan Silk Fibroin Acetone 
01 TSSF-NS1 0 1 0.5 
02 TSSF-NS2 1 1 0.5 
03 TSSF-NS3 1 2 0.5 
04 TSSF-NS4 1 3 0.5 
05 TSSF-NS5 1 4 0.5 
#
 
TS-SFNS1 (Blank nanosphere) 
Table 2: Evaluation of formulation batches of silk fibroin nanospheres of telmisartan mean particles size, entrapment efficiency, and drug loading 
S. No. Formulations Evaluation parameters 
Yielda Entrapment efficiency(%) a Drug loading(%) a Particle size (%) a (nm) 
01 TSSF-NS1 29.52±0.20 00.00±0.00 00.00±0.00 152.10±2 
02 TSSF-NS2 42.18±0.23 52.22±0.11 22.14±0.06 160.12±3 
03 TSSF-NS3 53.22±0.14 59.26±0.36 27.22±0.11 168.22±2 
04 TSSF-NS4 46.29±0.04 66.17±0.15 31.04±0.34 174.09±4 
05 TSSF-NS5 58.13±0.21 74.22±0.17 35.21±0.02 186.11±1 
a
 
data are given in mean±SD, n=3, nm=nanometer 
The entrapment efficiency and drug loading of silk fibroin nanospheres 
of telmisartan varies from 52.22±0.11 to 74.22±0.17 % and 22.14±0.06 
to 35.21±0.02 % respectively. It was found that silk fibroin nanospheres 
of telmisartan TSSF-NS5 showed highest 74.22±0.17 % entrapment 
efficiency and 35.21±0.02 % drug loading due to the proper bounding of 
telmisartan with the β-sheets of silk fibroin. 
Particle size, zeta potential, and Stability of nanospheres 
We first experienced the result of varying polymer concentrations 
by dilution on particle sizes. In this experiment, the weight ratio of 
silk fibroin solution was increased gradually from 1/1 to 1/4, while 
keeping the acetone in solution at constant. The particle size varies 
from 152.10±2 nm to 186.11±1 nm with (fig. 1) and without drug.  
 
 
Fig. 1: Particle size of blank silk fibroin nanosphere 
Cumulative analysis of particle size analysis records collected from 
the 1/1 sample showed a relatively lower size allocation with a 
mean sphere size of 160.12 nm±3. The 1:2 and 1:4 samples, though, 
have bigger mean sizes (168.22±2 and 186.11±1, respectively) and a 
wide sphere size division ranging from 150 nm to 200 nm.  
 
 
Fig. 2: Particle size of silk fibroin nanosphere loaded of 
telmisartan (TSSF-NS5) 
 
In consideration of information in the literature on silk fibroin 
nanosphere’s [30], using organic solvents with diverse molecular 
weights can as well modify mean sphere size and its size 
distribution. Although to reduce particle size we treated the above 
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experiment with the constant volume of acetone. It was found that 
optimized silk fibroin nanosphere of telmisartan (TSSF-NS5) showed 
particle size of 186.11±1 nm (fig. 2) particle size due to the 
availability of numbers of TS molecule and combined interaction 
with β-sheets of silk fibroin.  
The silk fibroin nanosphere loaded with telmisartan TS-SFNS5 with 
zeta potential above±10 mV have been shown to be stable, as the 
surface charge prevents aggregation of the particles.  
As shown in (table 3) and (fig. 3), the value of zeta potential (-13.3 
mV) showed that prepared silk fibroin nanoparticle with telmisartan 
TSSF-NS5 has sufficient charge and mobility to inhibit aggregation of 
particles. 
 
Fig. 3: Zeta-potential of silk fibroin nanosphere loaded with 
telmisartan (TSSF-NP5
 
Table 3: Evaluation of formulation batches of silk fibroin nanospheres of Telmisartan for Particle size and zeta potential 
S. No. Formulation code Particle size (nm) Zeta potential (ζ)a b 
01 TSSF-NS1 152.10±2 -4.9 mV 
02 TSSF-NS2 160.12±1 -7.8 mV 
03 TSSF-NS3 168.22±4 -9.2 mV 
04 TSSF-NS4 174.09±3 -11.7 mV 
05 TSSF-NS5 186.11±1 -13.3 mV 
a,b
 
data are given in mean±SD, n=3, nm=nanometer 
The constancy of the sphere suspension, as noticed during sample 
storage at 4 °C for up to 3 mo, ensued a comparable fashion to the 
particle size, with the 50% sonicated sample found to be more 
stable. Hence, silk fibroin loaded with telmisartan nanospheres has 
the potential of physical stability. These nanospheres were found to 
be stable in de-ionized water over a longer period of time (table 4). 
  
Table 4: Determination of stability of telmisartan encapsulated silk fibroin nanospheres using the particle size analyzer in de-ionized water 
De-ionized water 
Time Particle size (nm) Zeta potential (ζ)a a 
1 h 183.10±1 -12.79 mV 
6 h 181.12±3 -11.88 mV 
12 h 186.22±1 -13.30 mV 
48 h 186.09±4 -13.11 mV 
96 h 182.09±2 -12.39 mV 




data are given in mean±SD, n=3 
The absorption bands in the frequency range of 1539–1623 cm-1 
were ascribed to the random coil of SF, 1271 and 1623 cm-1 ascribed 
to β-sheets. To ascertain the β-sheet content, FTIR was accomplished 
on silk fibroin loaded telmisartan nanospheres. In earlier studies 
with silk films/nanosphere, it has been established that the 
nanosphere’s originally demonstrated mostly amorphous structure 
(1532 cm-1) with a few silk I arrangement (1652 and 1655 cm-1) 
[31]. Following dealing with acetone, the silk I structure was 
predominant with the increased in the β-sheets formation of above 
40% β-sheets. FT-IR spectrum of TS displays distinctive peaks at 
3443 cm-1 (N–H stretch), 2959 cm−1 (aromatic C–H stretch), 2926 
cm−1 (aliphatic C–H stretch), 1698 cm-1(carbonyl group), 1453 cm−1 
express the existence of C=C aromatic group and the peak 1267 cmˉ1
  
 
for O-H stretching vibration as shown in (fig. 4). 
 
Fig. 4: (a) FTIR of Pure drug telmisartan, (b) FTIR of silk fibroin, (c) FTIR physical mixture of pure drug and polymer, and (d) FTIR of 
telmisartan nanosphere TSSF-NS5 by using FTIR-spectrophotometer shimadzu-8400 (scan range from 600-4000 cm-1) 
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FT IR spectrum of silk fibroin loaded telmisartan nanospheres 
(TSSF-NS5) also shows distinctive peaks at 3280 cm-1 (N–H stretch), 
3061 cm−1 (aromatic C–H stretch), 2870 cm−1 (aliphatic C–H stretch), 
1694 cm-1(carbonyl group), 1444 cm−1 signifies the aspect of (C=C)-
aromatic group and the peak 1267 cmˉ1
The DSC thermogram of pure telmisartan demonstrated a sharp 
peak at 273 °C (fig. 5), which coincides to the melting temperature of 
telmisartan, the sharpness of the peak of the drug demonstrating its 
crystalline nature and a single peak showed that the drug sample is 
free from any impurities. 
 for O-H stretching vibration. 
Presence of all these peaks and the paucity of some fresh peaks in 
the TSSF-NS5 formulation indicates no chemical communion 
amongst the drug and polymer. 
DSC studies 
The thermogram of silk fibroin showed a peak at 320 ° C, which 
corresponds to its melting temperature. In the optimized 
formulation, telmisartan-loaded silk fibroin (TSSF-NS5) sharp drug: 
peaks were observed first at 268 °C indicating that the crystallinity 
of the drug was reduced and it might be converted to amorphous 
form. Although typical endothermic peak similarly to the drug 
melting expanded and moved towards lower temp., with the lower 
intensity in SFNS’s formulation. This might be ascribed to the shift of 
crystalline description of the drug in the TSSF-NS5. 
 
 
Fig. 5: (a) DSC of silk fibroin, (b) DSC of telmisartan, and (c) DSC of silk fibroin nanospheres TSSF-NS5 
 
XRD studies 
XRD arrangement of pure TS and TS-SFNS-5 is shown in (fig. 6). The 
diffraction pattern of TS asserted precisely the high-intensity peaks 
at diffraction angles (2θ) of 6.3 °, 10.1 °, 15.53 °, 16.32 °, 17.5 °, 18.11 
°, 21.6 °, 23.6 °, and 25.21 ° implying that the drug endured as a 
crystalline material. 
The XRD pattern of TS-SFNS-5 exhibited an appreciable decline in 
the peak strength correlated with distinctive peaks of pure TS. This 
declined peak recommends modification of the drug chiefly into an 
amorphous shape. This distinct decline in peak strength furnishes an 
evidence for the important inflation in the disso-rates and, 
consequently bio-availability by SFNS formulation. 
  
 
Fig. 6: (a) XRD of Telmisartan, (b) XRD of Silk Fibroin, and (c) XRD of Silk Fibroin nanospheres TSSF-NS5 using X-ray diffractometer 
(Rigaku Ultima III, Rigaku Corporation) 2θ range of 0 ° to 45 °C 
 
SEM analysis 
The TS-loaded SFNS with bulbous in shape and had smooth surface 
can be prepared by the nanoprecipitation technique according to [7].  
 
As shown in (fig. 7), the results of SEM analysis indicated that the 
different drug loading contents did not affect to morphology and size 
of SF nanospheres. 
Wani et al. 




Fig. 7: SEM of silk fibroin nanospheres TSSF-NS5 using scanning electron microscope (Hitachi NORAN system 7) 
 
It should be noted that the nanoparticles with a spherical shape 
called as nanospheres should give steadier drug release than the 
nanospheres with uneven contour. 
In vitro drug release study 
For the drug release behaviors, the drug release increased as the 
decreasing drug ratio. The reason for this could be that the SF 
nanospheres with higher drug content predominantly contained the β-
sheet SF conformation as described in FTIR analysis. The drug was 
released from the higher content of β-sheet SF nanosphere matrix. 
Hence, related to phospholipids, the amphiphilic character of SF 
molecules facilitates the loading of both hydrophobic and hydrophilic 
drugs in SF NS’s owing to its inter-molecular interactions, with the 
possibility to manage drug loading and release by altering the degree of 
SF crystallinity (β-sheet) structure arrangement. As compared with 
extensively used lipid vesicles, due to their elevated molecular weight, 
amino acid composition, and unique structure, SF vesicles are more 
chemically and physically stable and more suitable for delivering macro-
molecular drugs. The SF NS’s reported in the present study, based on the 
ability to control size and shape, can be incorporated in these systems 
and used as a carrier for drug delivery. Silk microspheres and 
nanospheres prepared with different methods have also been reported 
[32-34]. Compared to these methods, the present study furnishes a 
singular method that can manage the size and shape of the nanospheres 
in accordance with detailed conditions. The method compels no organic 
solvents and no pricey apparatus during substance dispensation; as a 
result, this will be appropriate for the potential bio-medical and 
pharmaceutical applications for drug delivery. 
 
 
Fig. 8: % Cumulative percentage drug release of nanospheres of telmisartan TSSF-NS2 to TSSF-NS5 (mean±standard deviation, n = 3) 
 
Table 5: Correlation co-efficient, reaction rate-constants and diffusion-exponent of the model equations applied to the release of 
telmisartan from silk fibroin nanospheres 




































TSSF-NS= Telmisartan+Silk Fibroin Nanospheres, R2 is the coefficient of correlation, kH
 
 is the release rate constant of Higuchi model; and n is the release 
exponent of Korsemeyer-Peppas model, the release regression values (correlation coefficient values) were the greatest fitting with the Higuchi model, 
and the exponent values were established to lie between (0.912–0.996). Therefore, the (n) values are higher than 0.5 indicating a non Fickian release. 
The in vitro cumulative drug release of silk fibroin nanosphere of 
telmisartan (TSSFNS1-TSSF-NS5) showed that highest 96.04±0.22 % 
cumulative drug release of optimized TSSF-NS5 at the end of 24th hr. 
During in vitro drug release studies of silk fibroin loaded with 
telmisartan, it was found that about 74% (fig. 8) of drug was released 
within 8 h and about 96% of drug released at the end of 24th h.  
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Therefore, the optimized formulation of silk fibroin nanospheres 
loaded with telmisartan (TSSF-NS5) was apt to release the drug over 
the course of time. 
Release Kinetics 
The in vitro release kinetics was conducted out to ascertain the 
release system. The release constants were measured from the slope 
of the suitable plots, and regression coefficient (R2
CONCLUSION 
) by linear 
regression analysis. The 1st-order release values for formulations 
were 0.821–0.979 and 0.818–0.866 for zero order (table 5). 
The current study concludes that the nanoprecipitation method was 
found to be an encouraging technique for developing the dissolution 
of poor water soluble drug like TS. The SF loaded telmisartan 
nanospheres were successfully prepared by the nanoprecipitation 
process in acetone. The particle size increased with an increase in SF 
content. Polymer concentration influences drug loading and drug 
release from nanospheres. Generally, drug entrapment increases 
with increasing concentration of polymer. The β-sheet forms of SF 
nanosphere matrices were induced by both acetone treatment and 
telmisartan loading. The intermolecular interactions between SF and 
drug molecules also induced SF based β-sheet conformation as 
indicated from FTIR and DSC analysis. XRD and DSC studies 
indicated rebate in crystallinity, an aspect subsidizing to dissolution 
rate improvement of the drug. The different SF contents did not alter 
the design and size of SF nanospheres. The drug release rate from SF 
nanospheres increased as the β-sheet form of SF nanospheres was 
increased. It is believed that these SF nanospheres will find potential 
applications in drug delivery release as drug carriers, especially poor 
water-soluble drugs. 
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